z-logo
Premium
NF ‐ Y ‐dependent regulation of glutamate receptor 4 expression and cell survival in cells of the oligodendrocyte lineage
Author(s) -
Begum Ghazala,
Otsu Masahiro,
Ahmed Usman,
Ahmed Zubair,
Stevens Adam,
Fulton Daniel
Publication year - 2018
Publication title -
glia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.954
H-Index - 164
eISSN - 1098-1136
pISSN - 0894-1491
DOI - 10.1002/glia.23446
Subject(s) - excitotoxicity , biology , transcription factor , gene knockdown , oligodendrocyte , microbiology and biotechnology , programmed cell death , apoptosis , gene , neuroscience , genetics , central nervous system , myelin
Glutamate receptor subunit 4 (GluA4) is highly expressed by neural cells sensitive to excitotoxicity, and is the predominant subunit expressed by oligodendrocyte precursor cells (OPC) during a key period of vulnerability to hypoxic‐ischemic injury. Therefore, transcriptional networks downstream of excitotoxic GluA4 activation represent a promising area for therapeutic intervention. In this work, we identify the CCAAT binding transcription factor NF‐Yb as a novel transcriptional regulator of Gria4 (GluA4 gene), and a controller of excitotoxic death in the oligodendroglial lineage. We describe a novel regulatory region within Gria4 containing CCAAT sequences whose binding by NF‐Yb is regulated by excitotoxicity. Excitotoxicity‐induced alterations in NF‐Yb binding are associated with changes in Gria4 transcription, while knockdown of NF‐Yb alters the transcription of reporter constructs containing this regulatory region. Data from immortalized and primary OPC reveal that RNAi and pharmacological disruption of NF‐Yb alter Gria4 transcription, with the latter inducing apoptosis and influencing a set of apoptotic genes similarly regulated during excitotoxicity. These data provide the first definition of a trans‐acting mechanism regulating Gria4 , and identify the NF‐Y network as a potential source of pharmacological targets for promoting OPC survival.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here